This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Medical Affairs World Congress

$200 SAVINGS ENDS IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
November 7-8, 2022
Delivered as a Hybrid EventInn at Penn a Hilton Hotel, Philadelphia, PA

Track A: Medical Affairs Strategic Leadership

BUILDING THE MEDICAL AFFAIRS ORGANIZATION OF THE FUTURE TO DRIVE VALUE CREATION AND PRIORITIZE PATIENT-CENTRIC OUTCOMES 

*The Medical Affairs Strategic Leadership Track is open to CMOs, VPs, Senior/Executive Directors & Department Heads working in medical affairs or related functions. 

Medical Affairs Updates

Explore the next evolution of the Medical Affairs function as Patient-Centric Healthcare advances

  • Keynote: Exploring the Future of Medical Affairs with Darryl Sleep, MD, MBBCh, FCS(SA), Chief Medical Officer and Senior Vice President, Global Medical, Amgen 
  • Panel: Building the Medical Affairs Organization of the Future featuring Senior Leaders from Sanofi, AstraZeneca, ANI Pharmaceuticals, and Braeburn 
  • Debate: Practical Strategies for Evolving the Patient-Centric Medical Narrative with Leaders from Medical Affairs and Patient Advocacy at Agios Pharmaceuticals 
  • Defining Medical’s Role in Determining Patient Engagement Strategy with Executives from Aadi Bioscience, Inc and Abbott’s vascular business 

Learn Medical’s important role in leading the digital revolution

  • Panel: Commitment to Publishing and Navigating the Resulting Compliance Challenges and Open Access Publishing  
  • Digital Therapeutics – Co-existing in the Treatment Paradigm - Guidehouse 
  • Panel: Leveraging Technology to Optimize KOL Interactions 
  • A Showcase of Case Studies from Medical Affairs Leaders at Pfizer on RWE Capabilities and Data Demand 

Examine the impact of earlier involvement and partnerships with various departments and stakeholders

  • Forging an Integral Partnership with R&D Early in the Development Cycle 
  • Panel: Establishing a Collaborative Commercial and Medical Affairs Interface with Pfizer, AstraZeneca, and Vertex Pharmaceuticals 
  • Multistakeholder Panel: Frameworks to Balance Incentives for Reimbursement – Moderated by Shontelle Dodson, Executive Vice President and Head of Medical Affairs, Astellas, Inc. 
  • Advancing Health Equity and Inclusion in Clinical Trials